Designation: Assoc. Professor
University: Shanghai University
Country: United States
Da-Yong LU was born in July, 1962 in Shanghai. At present he is professor at Shanghai Institute of Materia Medica, Chinese Academy of Sciences since 2005. He has completed his MS at Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 1986. He has completed BS at Shanghai Medical University (Now Fudan University affiliated) in1982. He is working as an associate professor at Shanghai University, Shanghai200444, PR China. He has Undergone the studies of cancer pathology, biochemistry, pharmacology and clinical therapeutics, especially on the pharmacological studies of new Chinese anticancer agent probimane and MST-16 and antimetastatic targets of fibrinogen and sialic acids and individualized cancer chemotherapy (ICC) since 1982. His interest is to focus on the basic studies of cancer biology, pathology, treatment, origins of life, human suicide study, human viral infectious diseases, human metabolic diseases and other field of science disciplines. He is serving as an editorial member of several reputed international journals. He was the first author to have more than 100 original scientific articles in international journals and three books published by UK, US and Germany-based publication companies. He has also studied biochemical and pathological aspects of cancer diagnosis, neoplasm metastasis, anti-diabetic treatments, suicide preventions and deadliest viral infections, such as HIV/AIDS, Ebola, avian flu and others.
His research interests include drug development of cancer, mental diseases, metabolic disease treatments, prevention of viral infection and therapeutics. Nursery science and healthcare service.
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: email@example.com
Copyright © 2020 Boffin Access Limited.